Wohlwend, MartinAuwerx, JohanWisløff, UlrikMoreira, Jose Bianco2022-09-012022-09-012022-09-012022https://infoscience.epfl.ch/handle/20.500.14299/190499The present invention relates generally to the field of long non-coding RNAs and transcription factors and modulation of their expression for use in medicine and agriculture, such as the treatment and prevention of diseases associated with muscle atrophy and the production of livestock. More particularly, the invention provides agonists of Cytor, a long non-coding RNA, e.g. agents that increase the amount of Cytor RNA in skeletal muscle as well as antagonists for Teadl, a transcription factor, e.g. agents that decrease the amount of Teadl RNA or protein in skeletal muscle and their use in therapy.patentEP4291653WO2022171734GB20210193275338915